BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...Biosciences Inc. Obsidian Therapeutics Inc. Repertoire Immune Medicines Inc. GlaxoSmithKline plc Simcha Therapeutics Holding Co. LLC Xilio...
Items per page:
1 - 1 of 1
BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...Biosciences Inc. Obsidian Therapeutics Inc. Repertoire Immune Medicines Inc. GlaxoSmithKline plc Simcha Therapeutics Holding Co. LLC Xilio...
Items per page:
1 - 1 of 1